Evolva
Provides products that can contribute to health, wellbeing and sensory enjoyment.
- biotechnology
- horizon europe
- sustainable development goals
- dt and ls
- woman founder
- supply chain management
- genetics and genomics
- industrial technology
- dna
- alternative protein
- nutrition
- genome engineering
- non-invasive medical devices and treatments
- plant-based
- synthetic biology
- nutrition solution
- taste
- flavor
- ingredient
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | $23.5m Valuation: $23.5m | Acquisition | |
| Total Funding | 000k | ||
Swisscom Ventures(exited)
Wellington Partners(exited)
Aravis Ventures(exited)
Vinci Capital(exited)
Heartcore Capital(exited)
Eurostars SME programme(exited)
Auriga Partners(exited)
BioMed Partners(exited)
Entrepreneurs Fund(exited)
Astellas Venture(exited)
Sunstone Life Science Ventures(exited)
Auriga Partners (Paris)(exited)
Adrian Bührer(exited)
Andrea Jansen(exited)
Dario Fazlic(exited)
Novartis Venture Fund(exited)
Nice&Green SA(exited)
Myke Näf(exited)
| CHF | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 33 % | 45 % | (35 %) | 31 % | 57 % | (39 %) | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 288 % | (139 %) | (276 %) | (322 %) | (227 %) | (443 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 363 % | (187 %) | (396 %) | (418 %) | (279 %) | (1115 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 118 % | 180 % | 227 % | 152 % | 340 % | - |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
